EirGenix Inc. (TPE:6589)
Taiwan
· Delayed Price · Currency is TWD 75.30
-0.30 (-0.40%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Biopharmaceuticals | 1.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceuticals Growth | -1.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Japan | 359.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 92.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan | 338.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | -28.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States and Canada | 165.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States and Canada Growth | 39.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 143.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -40.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong, Macau and China | 1.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong, Macau and China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|